Haemonetics Corp (NYSE:HAE)

93.04
Delayed Data
As of Jun 22
 -0.49 / -0.52%
Today’s Change
38.47
Today|||52-Week Range
96.84
+60.19%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$4.7B

Company Description

Haemonetics Corp. is a healthcare company, which engages in the development and distribution of hematology products and solutions. It operates through the following geographical segments: Japan, EMEA (Europe, the Middle East, and Africa), North America Plasma, and All Other. Its products include surgical and diagnostic devices, blood and plasma center devices, blood center software, hospital software, and plasma center software. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Braintree, MA.

Contact Information

Haemonetics Corp.
400 Wood Road
Braintree Massachusetts 02184-9114
P:(781) 848-7100
Investor Relations:
(781) 356-9402

Employees

Shareholders

Mutual fund holders58.63%
Other institutional43.29%
Individual stakeholders2.06%

Top Executives

Christopher SimonPresident, Chief Executive Officer & Director
Neil RydingExecutive Vice President-Global Operations
William P. BurkeCFO, EVP, Head-Business Development
Said BolorforoshChief Technology Officer & Executive VP
Michelle L. BasilExecutive Vice President & General Counsel